================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 SEPTEMBER 29, 2004 Date of Report (Date of earliest event reported) ORAGENICS, INC. (Exact name of registrant as specified in its charter) FLORIDA 000-50614 59-3410522 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 12085 RESEARCH DRIVE ALACHUA, FLORIDA 32615 (Address of principal executive offices including zip code) (386) 418-4018 Registrant's telephone number, including area code NONE (Former name or former address, if changed since last report.) ================================================================================ ITEM 7.01 REGULATION FD DISCLOSURE Oragenics, Inc. announces that it has hired Edmund Mickunas for the position of Vice President, Regulatory and Clinical Affairs. ITEM 9.01 FINANCIAL INFORMATION AND EXHIBITS EXHIBIT NO. DESCRIPTION 99.1 Press Release SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 29th day of September, 2004. ORAGENICS, INC. (REGISTRANT) BY: /s/ Mento A. Soponis Mento A. Soponis President and Chief Executive Officer